Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Navvi ( the leading digital prescription marketplace, today announced the integration of Integrity Compounding Pharmacy into its curated pharmacy network. This strategic addition brings a ...

May 29—(StatePoint) Most consumers know how a traditional pharmacy works. Far fewer are aware of an alternative option: a compounding pharmacy. Here's everything you need to know about these ...

ALEXANDRIA, VA, UNITED STATES, January 26, 2026 / EINPresswire.com / — The Alliance for Pharmacy Compounding (APC) today announced a new, exclusive accreditation partnership with Coalition for ...

ORLANDO, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of the nation’s leading compounding pharmacies, are proud to announce that their Chief Executive Officer, Mark ...

LifeMD stock is rated a buy with an FY 2026 target price of ~$6, implying over 85% upside from current levels. Click here to ...

The Food and Drug Administration announced that branded tirzepatide, the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely prevent ...

(ProRx Pharma) - From hospitals to surgical centers, med spas to even your dentist’s office—chances are, you or someone in your family has already received medication from a compounding pharmacy ...

Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like diet, ...

It is easy to differentiate between your local community pharmacy and a large pharmaceutical manufacturer. The pharmacy is viewed as dispensing medications to particular patients with prescriptions ...

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more here.

The MarketWatch News Department was not involved in the creation of this content. Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient ...